Dose-response and mechanism of protective functions of selective alpha-2 agonist dexmedetomidine on acute lung injury in rats

Saudi Medical Journal

Volumn 33, Issue 4, 2012, Pages 375-381

  Shi, Qi Qing ^a,b   Wang, Hao ^a   Fang, Hao ^a  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LYMPHOTOXIN; MESSENGER RNA; SODIUM CHLORIDE; TOLL LIKE RECEPTOR 4;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRY WEIGHT; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; NONHUMAN; ORGAN WEIGHT; PNEUMONIA; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACUTE LUNG INJURY; ADRENERGIC ALPHA-AGONISTS; ANIMALS; BASE SEQUENCE; DEXMEDETOMIDINE; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84859722711     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Rubenfeld GD, Herridge MS. Epidemiology and outcomes of acute lung injury. Chest 2007; 131: 554-562.
2. Mantz J, Josserand J, Hamada S. Dexmedetomidine: new insights. Eur J Anaesthesiol 2011; 28: 3-6.
3. Memis D, Hekimoglu S, Vatan I, Yandim T, Yuksel M, Sut N. Effects of midazolam and dexmedetomidine on inflammatory responses and gastric intramucosal pH to sepsis, in critically ill patients. Br J Anaesth 2007; 98: 550-552.
4. Zimmerman JJ, Akhtar SR, Caldwell E, Rubenfeld GD. Incidence and outcomes of pediatric acute lung injury. Pediatrics 2009; 124: 87-95.
5. Bae HB, Li M, Kim JP, Kim SJ, Jeong CW, Lee HG, et al. The effect of epigallocatechin gallate on lipopolysaccharide-induced acute lung injury in a murine model. Inflammation 2010; 3: 82-91.
6. Rojas M, Woods CR, Mora AL, Xu J, Brigham KL. Endotoxininduced lung injury in mice: structural, functional, and biochemical responses. Am J Physiol Lung Cell Mol Physiol 2005; 288: L333-L341.
7. Kim JH, Suk MH, Yoon DW, Kim HY, Jung KH, Kang EH, et al. Inflammatory and transcriptional roles of poly (ADP-ribose) polymerase in ventilator-induced lung injury. Crit Care 2008; 12: R108.
8. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420: 885-891.
9. Hoy SM, Keating GM. Dexmedetomidine: a review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation. Drugs 2011; 71: 1481-1501.
10. Mason KP, Zurakowski D, Zgleszewski SE, Robson CD, Carrier M, Hickey PR, et al. High dose dexmedetomidine as the sole sedative for pediatric MRI. Paediatr Anaesth 2008; 18: 403-411.
11. Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007; 298: 2644-2653.
12. Ziolo MT, Katoh H, Bers DM. Expression of inducible nitric oxide synthase depresses beta-adrenergic-stimulated calciumrelease from the sarcoplasmic reticulum in intact ventricular myocytes. Circulation 2001; 104: 2961-2966.
13. Chen Y, Zhao Z, Code WE, Hertz L. A correlation between dexmedetomidine-induced biphasic increases in free cytosolic calcium concentration and energy metabolism in astrocytes. Anesth Analg 2000; 91: 353-357.
14. Gyires K, Zádori ZS, Shujaa N, Al-Khrasani M, Pap B, Mózes MM, et al. Pharmacological analysis of alpha(2)-adrenoceptor subtypes mediating analgesic, anti-inflammatory and gastroprotective actions. Inflammopharmacology 2009; 17: 171-179.